Elicio Therapeutics (ELTX) EBT Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | -1.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.40% |
| Dec 31, 2025 | 33.05% |
| Sep 30, 2025 | 19.66% |
| Jun 30, 2025 | 6.64% |
| Mar 31, 2025 | -5.68% |
| Dec 31, 2024 | -47.12% |
| Sep 30, 2024 | 2.19% |
| Jun 30, 2024 | -28.21% |
| Mar 31, 2024 | -24.46% |
| Dec 31, 2023 | -55.37% |
| Sep 30, 2023 | -53.93% |
| Jun 30, 2023 | -15.80% |
| Mar 31, 2023 | 43.82% |
| Dec 31, 2022 | -140.99% |
| Sep 30, 2022 | 56.61% |
| Jun 30, 2022 | 59.99% |
| Mar 31, 2022 | 27.35% |
| Dec 31, 2021 | 205.66% |
| Sep 30, 2021 | -36.02% |
| Jun 30, 2021 | -5.65% |
| Mar 31, 2021 | -58.64% |